Inadequately Controlled Asthma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15090 | Tezepelumab | A human monoclonal IgG2λ thymic stromal lymphopoietin (TSLP)-blocking antibody for add-on maintenance therapy in severe asthma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15090 | Tezepelumab | Thymic stromal lymphopoietin | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12169 | Tralokinumab | 3 | Terminated | 1 |